Table 4 Testing for BRCA Pathogenic Variants by Patient and Physician Characteristics
N Patients | Patients tested, n (%) | Patients with any pathogenic varianta, n (%) | |
|---|---|---|---|
All patients | |||
Total patients included in the study | 410 | 384 (93.7) | 115 (29.9) |
Race | |||
White | 302 | 284 (94.0) | 94 (33.1) |
Black or African American | 69 | 63 (91.3) | 15 (23.8) |
Asian | 27 | 26 (96.3) | 4 (15.4) |
Native Hawaiian | 1 | 0 (0.0) | N/A |
Other | 11 | 11 (100.0) | 2 (18.2) |
Cancer stage | |||
Metastatic breast cancer | 124 | 114 (91.9) | 42 (36.8) |
Early breast cancer | 286 | 270 (94.4) | 73 (27.0) |
Clinical characteristics | |||
Metastatic and triple negative breast cancer | 34 | 33 (97.1) | 17 (51.5) |
Metastatic and HER2(−) breast cancer | 105 | 98 (93.3) | 39 (39.8) |
Triple negative breast cancer | 126 | 121 (96.0) | 50 (41.3) |
Genetic counselor | |||
Yes | 270 | 256 (94.8) | 82 (32.0) |
No | 140 | 128 (91.4) | 33 (25.8) |